Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia ; volume:15 ; number:1 ; day:26 ; month:4 ; year:2016 ; pages:1-9 ; date:12.2016
Annals of clinical microbiology and antimicrobials ; 15, Heft 1 (26.4.2016), 1-9, 12.2016
- Urheber
-
Wong, Davie
- Beteiligte Personen und Organisationen
-
Wong, Titus
Romney, Marc
Leung, Victor
SpringerLink (Online service)
- DOI
-
10.1186/s12941-016-0143-3
- URN
-
urn:nbn:de:1111-201604279079
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wong, Davie
- Wong, Titus
- Romney, Marc
- Leung, Victor
- SpringerLink (Online service)
Ähnliche Objekte (12)
Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Expression of Concern to: Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
![Valclavam - ein antifungisches β-Lactam [Beta-Lactam], Fermentation, Isolierung, Biogenese und biologische Wirkung](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Valclavam - ein antifungisches β-Lactam [Beta-Lactam], Fermentation, Isolierung, Biogenese und biologische Wirkung
Molecular biotechnology of fungal β-lactam [beta-lactam] antibiotics and related peptide synthetases
Low level β-lactamase production in methicillin-resistant staphylococcus aureus strains with β-lactam antibiotics-induced vancomycin resistance
β-lactam antibiotic concentrations during continuous renal replacement therapy
Molecular modeling studies of lipase-catalyzed β-lactam polymerization
Staphylococcus aureus functional amyloids catalyze degradation of β-lactam antibiotics
Time-resolved β-lactam cleavage by L1 metallo-β-lactamase
Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Expression of Concern to: Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
Valclavam - ein antifungisches β-Lactam [Beta-Lactam], Fermentation, Isolierung, Biogenese und biologische Wirkung
Molecular biotechnology of fungal β-lactam [beta-lactam] antibiotics and related peptide synthetases
Low level β-lactamase production in methicillin-resistant staphylococcus aureus strains with β-lactam antibiotics-induced vancomycin resistance
β-lactam antibiotic concentrations during continuous renal replacement therapy
Molecular modeling studies of lipase-catalyzed β-lactam polymerization
Staphylococcus aureus functional amyloids catalyze degradation of β-lactam antibiotics
Time-resolved β-lactam cleavage by L1 metallo-β-lactamase
Editorial Expression of Concern: Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Expression of Concern to: Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study
Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
Valclavam - ein antifungisches β-Lactam [Beta-Lactam], Fermentation, Isolierung, Biogenese und biologische Wirkung
Molecular biotechnology of fungal β-lactam [beta-lactam] antibiotics and related peptide synthetases
Low level β-lactamase production in methicillin-resistant staphylococcus aureus strains with β-lactam antibiotics-induced vancomycin resistance
β-lactam antibiotic concentrations during continuous renal replacement therapy
Molecular modeling studies of lipase-catalyzed β-lactam polymerization
Staphylococcus aureus functional amyloids catalyze degradation of β-lactam antibiotics